Damona Pharmaceuticals

Private

TorontoHealthcare & Life Scienceshttps://www.damonapharma.com/

Last Round

Seed

Sep 26, 2022

Total Funding Raised

$5.5M

Company Overview

Damona Pharmaceuticals is a biopharmaceutical company that develops small molecule therapeutics designed to restore cognitive function across neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule therapeuticscognitive impairmentdrug discoveryprecision medicineclinical-stage biotechneurodegenerative diseaseCNS disordersclinical trialsdrug developmentbiotech startupneuroscience researchtherapeutic pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Damona Pharmaceuticals Comparables

Compare Damona Pharmaceuticals with similar companies based on industry and business-model similarity.

Damona Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Gabather AB	84%
Avenue Therapeutics Inc	78%
Praxis Precision Medicines, Inc.	77%

View all Comparables

Damona Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 26, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

John Reilly

Chief Executive Officer

Executive Team

Damona Pharmaceuticals Investors

Notable investors and investment history

Damona Pharmaceuticals investors
Investor	Rounds
Ontario Brain Institute	Seed
Noetic Fund	Seed
Angelini Ventures	Seed
Lumira Ventures	Seed
TIAP	Seed

View all Investors

Damona Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Damona Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Damona Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto

Employee Range4

Year Founded2019

Last FundingSep 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.